<DOC>
	<DOCNO>NCT00736957</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety tramadol hydrochloride plus acetaminophen ( JNS013 ) long term administration participant chronic pain .</brief_summary>
	<brief_title>A Long-term Efficacy Safety Study Tramadol Hydrochloride Plus Acetaminophen ( JNS013 ) Japanese Participants With Chronic Pain</brief_title>
	<detailed_description>This open-label ( physician participant know name study drug ) , non-randomized , multicenter ( one hospital medical school team work medical research study ) long-term efficacy safety study JNS013 ( combination tramadol hydrochloride ( TRAM ) acetaminophen [ APAP ] ) participants chronic pain ( ache sensation persist month . It may may associate trauma disease , may persist initial injury heal . Its localization , character , time vague acute pain ) . This study consist 4 period ; screen period : 1 week , treatment period I : 4 week , treatment period II : 48 week follow-up period : 1 week . During Treatment Period I , restriction concomitant treatment establish participant treat one two tablet JNS013 , four time daily four week . During Treatment Period II , participant treat 48 week use dose method dose level JNS013 use Treatment Period I , permit modification concomitant drugs/therapies normal medical care . Throughout Treatment Period I Treatment Period II , decision make permit participant select use either one two tablet JNS013 per dose accord extent participant 's pain tolerability . The total duration treatment period 52 week . Efficacy assess use change baseline Visual Analogue Scale pain ( VAS24 ) score pre-defined time point Week 52 . Participants safety monitor throughout study .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Participants whose pain control sufficiently least 14day continuous treatment identical oral non steroid anti inflammatory drug ( NSAIDs ) usual maximum dose 3 month prior study Ambulatory participant without need supportive device assistance daily life Outpatients Participants plan change therapeutic policy content medication underlie disease screen period end Treatment Period I Sustention chronic pain due Osteo Arthritis ( OA ) , Low Back Pain ( LBP ) , Rheumatoid Arthritis ( RA ) , Neck Shoulder Arm Syndrome ( NSAS ) , Diabetic Neuropathy ( DN ) , Post herpetic Neuralgia ( PHN ) least 3 month Participants condition opioids contraindicate Participants condition APAP contraindicate Participants history convulsion possibility convulsive seizure Participants concurrent , previous , possible alcohol dependence , drug dependence , narcotic addiction Pregnant Participants may pregnant , lactate mother , Participants wish pregnancy study period .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Chronic Pain</keyword>
	<keyword>Acetaminophen</keyword>
	<keyword>Tramadol</keyword>
	<keyword>JNS013</keyword>
</DOC>